ArticleJAR life2025
Predicting dementia risk using neuroimaging and cognitive assessment.
Article in JAR life, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Dementia affects over 55 million people globally, with numbers expected to double in the coming decades. Early detection is critical, yet traditional risk assessments relying on age, family history, and basic cognitive tests often fall short. This study explores whether combining structural brain imaging with brief cognitive assessments can more accurately predict dementia risk. Method: Using data from 312 older adults enrolled in the KU Alzheimer's Disease Center cohort, researchers evaluated two modeling approaches: one based on a single clinic visit and another using longitudinal data across multiple visits. Participants underwent cognitive testing and MRI scans, including measures of hippocampal volume, gray matter, and Alzheimer's disease signature regions. Depressive symptoms were also assessed using the Geriatric Depression Scale (GDS). Results: Results showed that models incorporating neuroimaging significantly outperformed those using demographics or cognitive scores alone. The best-performing model combined imaging and cognitive data, achieving 77.6% accuracy in predicting dementia status. Longitudinal models further improved prediction by capturing changes over time, with imaging features contributing most to explained variance. Key predictors included reduced hippocampal volume, lower gray matter, and higher GDS scores. These findings align with known patterns of neurodegeneration and suggest that depression may interact with brain changes to influence dementia risk. Conclusion: Importantly, the study demonstrates that a compact, multimodal approaching standard MRI scans with brief cognitive tests-can generate individualized risk profiles suitable for clinical use. This method offers a scalable path to early intervention, trial enrollment, and personalized care planning. Future work will focus on validating these models in more diverse populations and integrating fluid biomarkers to enhance precision. Ultimately, this research supports the development of practical tools for forecasting dementia risk and advancing preventive strategies in aging populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.